InsidersTradesSigma
申报总数
公司
▲ 买入（1 笔）
▼ 卖出（1 笔）
内部人交易记录
董事已披露买入
1
已披露卖出
1
T+90 胜率
0%
T+90 平均收益
-24.6%
基于 1 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
信号历史
Explore the detailed record of transactions filed by Alva Emily Peterson, 董事. Director active across 2 companies, notably Amneal Pharmaceuticals, Inc.. Cumulatively, 13 disclosures have been recorded. Breakdown: 1 buy · 1 sell. Total volume traded: €712k. Activity tracked since 23 August 2021. The latest transaction was filed on 5 March 2025 (Cession). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to Alva Emily Peterson
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报13 总计
40,258 股Class A Common StockSEC:0001628280-25-023987:0
80,000 股@ US$8.90100.0% 占其流量Class A Common StockSEC:0001628280-25-011300:0
6,104 股Ordinary SharesSEC:0001127602-24-019581:0
3,871 股Ordinary SharesSEC:0001127602-24-018322:0
76,453 股Class A Common StockSEC:0001628280-24-023262:0
5,957 股Ordinary SharesSEC:0001127602-23-020544:0
3,795 股Ordinary SharesSEC:0001127602-23-018599:0
80,128 股Class A Common StockSEC:0001209191-23-028737:0
7,585 股Ordinary SharesSEC:0001127602-22-017630:0
532 股Ordinary SharesSEC:0001127602-22-017240:0
35,406 股Class A Common StockSEC:0001209191-22-028162:0
1,650.165 股@ US$30.2154100.0% 占其流量Ordinary SharesSEC:0001127602-21-024274:0
标准退出：2021年11月21日 (T+90)
46,218 股Class A Common StockSEC:0001209191-21-030814:0
13 条申报中的 13 条
About Alva Emily Peterson
Emily Peterson Alva is a Board Member at Amneal Pharmaceuticals, Inc. and Alkermes plc. She contributes to overseeing operations and shaping the strategic direction of these companies. Emily is committed to promoting best governance practices.
